Hangzhou Tigermed Consulting Co., Ltd. - Dividend Yield
HNGZY
Price:
$4
Market Cap:
$29.60B
Hangzhou Tigermed Consulting Co., Ltd. operates as a prominent contract research organization (CRO), delivering an extensive array of services across the People's Republic of China and globally. Its operations are strategically segmented into Clinical Trial Solutions and Clinical-related and Laboratory Services. The firm's comprehensive offerings include critical regulatory support like submission and approval navigation, medical translation, and Good Manufacturing Practice (GMP) consulting. For clinical development, Tigermed provides end-to-end services, encompassing medical science guidance, early to late-phase study execution, medical monitoring, meticulous project management, efficient p...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2022-07-11
Stock Exchange
OTC
Ticker
HNGZY
PE Ratio
[26.67]
ROE
[3.69%]
Current Ratio
[2.30]
Dividend Yield
[0.75%]
Enterprise Value
[29.16B]
Dividend History
The Dividend Yield as of June 2026 (TTM) for Hangzhou Tigermed Consulting Co., Ltd. (HNGZY) is 0.75%
According to Hangzhou Tigermed Consulting Co., Ltd.’s latest financial reports and current stock price. The company's current Dividend Yield is 0.75%. This represents a change of 310.92% compared to the average of 0.18% of the last 4 quarters.
Hangzhou Tigermed Consulting Co., Ltd. (HNGZY) Historical Dividend Yield (quarterly & annually)
How has HNGZY Dividend Yield performed in the past?
The mean historical Dividend Yield of Hangzhou Tigermed Consulting Co., Ltd. over the last ten years is 0.61%. The current 0.75% Dividend Yield has changed 22.19% with respect to the historical average. Over the past ten years (40 quarters), HNGZY's Dividend Yield was at its highest in in the September 2024 quarter at 0.91%. The Dividend Yield was at its lowest in in the September 2021 quarter at 0%.
Average
0.61%
Median
0.47%
Minimum
0.21%
Maximum
1.36%
Hangzhou Tigermed Consulting Co., Ltd. (HNGZY) Dividend Yield by Quarter and Year
Discovering the peaks and valleys of Hangzhou Tigermed Consulting Co., Ltd. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 169.47%
Maximum Annual Dividend Yield = 1.36%
Minimum Annual Increase = -47.89%
Minimum Annual Dividend Yield = 0.21%
| Year | Dividend Yield | Change |
|---|---|---|
| 2025 | 0.71% | -47.89% |
| 2024 | 1.36% | 5.95% |
| 2023 | 1.29% | 169.47% |
| 2022 | 0.48% | 102.92% |
| 2021 | 0.24% | 11.91% |
| 2020 | 0.21% | -43.41% |
| 2019 | 0.37% | -42.58% |
| 2018 | 0.65% | 82.25% |
| 2017 | 0.35% | -23.98% |
| 2016 | 0.47% | 30.18% |
Hangzhou Tigermed Consulting Co., Ltd. (HNGZY) Average Dividend Yield
How has HNGZY Dividend Yield performed in the past?
The current Dividend Yield of Hangzhou Tigermed Consulting Co., Ltd. (HNGZY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.12%
5-year avg
0.81%
10-year avg
0.61%
Hangzhou Tigermed Consulting Co., Ltd. (HNGZY) Dividend Yield vs. Peers
How is HNGZY’s Dividend Yield compared to its peers?
Hangzhou Tigermed Consulting Co., Ltd.’s Dividend Yield is greater than McKesson Europe AG (0%), less than Dechra Pharmaceuticals PLC (0.32%), less than Dechra Pharmaceuticals PLC (0.32%), greater than Mediclinic International plc (0%), less than Sugi Holdings Co.,Ltd. (1.12%), less than Galenica AG (2.97%), greater than Abcam plc (0%), less than IHH Healthcare Berhad (1.19%), greater than Takara Bio Inc. (0%), less than Ipsen S.A. (1.02%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $5.37B | |
| 0.32% | $5.34B | |
| 0.32% | $5.58B | |
| 0% | $4.05B | |
| 1.12% | $2.95B | |
| 2.97% | $5.73B | |
| 0% | $5.12B | |
| 1.19% | $15.11B | |
| 0% | $879.03M | |
| 1.02% | $9.35B |
Build a custom stock screener for Hangzhou Tigermed Consulting Co., Ltd. (HNGZY) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hangzhou Tigermed Consulting Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Hangzhou Tigermed Consulting Co., Ltd. (HNGZY) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Hangzhou Tigermed Consulting Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Hangzhou Tigermed Consulting Co., Ltd.'s Dividend Yield?
How is the Dividend Yield calculated for Hangzhou Tigermed Consulting Co., Ltd. (HNGZY)?
What is the highest Dividend Yield for Hangzhou Tigermed Consulting Co., Ltd. (HNGZY)?
What is the 3-year average Dividend Yield for Hangzhou Tigermed Consulting Co., Ltd. (HNGZY)?
What is the 5-year average Dividend Yield for Hangzhou Tigermed Consulting Co., Ltd. (HNGZY)?
How does the current Dividend Yield for Hangzhou Tigermed Consulting Co., Ltd. (HNGZY) compare to its historical average?